Company Filing History:
Years Active: 2016-2025
Title: Norbert Zilka: Innovator in Alzheimer's Disease Research
Introduction
Norbert Zilka is a prominent inventor based in Senec, Slovakia, known for his significant contributions to the field of neurodegenerative diseases, particularly Alzheimer's disease. With a total of 5 patents, Zilka has focused on developing innovative therapeutic and diagnostic solutions that address the challenges posed by tau-mediated pathologies.
Latest Patents
One of Zilka's latest patents is centered around a protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease. This invention provides unique therapeutic and diagnostic antibodies, along with their fragments, portions, derivatives, and variants, that specifically bind to regions of the tau protein. These regions are crucial for the initiation and propagation of pathological tau-tau interactions. The invention outlines methods for creating these antibodies and their applications in diagnostics, prevention, and treatment of Alzheimer's disease and related tauopathies. Furthermore, it introduces a method for prophylactic and therapeutic treatment of Alzheimer's disease and other neurodegenerative tauopathies. This method involves the injection of antibodies and/or peptide vaccines that elicit an immune response directed at pathological tau proteins and tau deposits in the brains of patients. The suitable vaccines include tau peptides carrying one or more of the therapeutic epitopes provided in the invention.
Career Highlights
Norbert Zilka is associated with Axon Neuroscience SE, a company dedicated to advancing research in neurodegenerative diseases. His work has been instrumental in developing innovative solutions that aim to improve the lives of patients suffering from Alzheimer's disease.
Collaborations
Zilka collaborates with notable colleagues, including Eva Kontseková and Branislav Kovácech, who contribute to the research and development efforts at Axon Neuroscience SE.
Conclusion
Norbert Zilka's innovative work in the field of Alzheimer's disease research highlights his commitment to finding effective therapies and diagnostics for neurodegenerative conditions. His contributions are paving the way for advancements in the treatment of tau-mediated pathologies.